Familial ALS/FTD-associated RNA-binding deficient TDP-43 mutants cause neuronal and synaptic transcript dysregulation in vitro
Open accessPublished version of a preprint
The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index; none of the 84 sources its claims cite is checked for support yet.
Abstract
TDP-43 is an RNA-binding protein constituting the pathological inclusions observed in ~ 95% of ALS and ~ 50% of FTD patients. In ALS and FTD, TDP-43 mislocalises to the cytoplasm and forms insoluble, hyperphosphorylated and ubiquitinated aggregates that enhance cytotoxicity and contribute to neurodegeneration. Despite its primary role as an RNA/DNA-binding protein, how RNA-binding deficiencies contribute to disease onset and progression are little understood. Among many identified familial mutations in TDP-43 causing ALS/FTD, only two mutations cause an RNA-binding deficiency, K181E and K263E. In this study, we used CRISPR/Cas9 to knock-in the two disease-linked RNA-binding deficient mutations in SH-SY5Y cells, generating both homozygous and heterozygous versions of the mutant TDP-43 to investigate TDP-43-mediated neuronal disruption. Significant changes were identified in the transcriptomic profiles of these cells, in particular, between K181E homozygous and heterozygous cells, with the most affected genes involved in neuronal differentiation and synaptic pathways. This result was validated in cell studies where the neuronal differentiation efficiency and neurite morphology were compromised in TDP-43 cells compared to unmodified control. Interestingly, divergent neuronal regulation was observed in K181E-TDP-43 homozygous and heterozygous cells, suggesting a more complex signalling network associated with TDP-43 genotypes and expression level which warrants further study. Overall, our data using cell models expressing the ALS/FTD disease-causing RNA-binding deficient TDP-43 mutations at endogenous levels show a robust impact on transcriptomic profiles at the whole gene and transcript isoform level that compromise neuronal differentiation and processing, providing further insights on TDP-43-mediated neurodegeneration.
Overview
CoChat Summary
TL;DR
CRISPR/Cas9 knock-in of the ALS/FTD-associated RNA-binding-deficient TDP-43 mutants K181E and K263E in SH-SY5Y cells caused transcriptomic and isoform dysregulation, especially in neuronal and synaptic pathways. K181E homozygous and heterozygous cells showed opposing expression patterns, with functional consequences for neuronal differentiation and neurite growth.
Key findings
- K181E-TDP-43 cells showed 233 differentially expressed genes (DEGs) in homozygous and 167 in heterozygous cells versus wild-type control (q<0.1), while 997 genes differed significantly between K181E homozygous and heterozygous cells (q<0.05).
- Neuronal/synaptic genes were down-regulated in K181E homozygous cells but up-regulated in K181E heterozygous cells, including known TDP-43 targets STMN2, UNC13A and NPTX2; K263E cells showed no significant DEGs in the undifferentiated state.
- Isoform switching analysis identified ~7000 significant isoform changes in K181E homozygous and ~400 in K181E heterozygous cells versus wild-type (q<0.05), and ~10,000 between K181E homozygous and heterozygous cells; K181E homozygous cells showed a complete switch from canonical DCTN1-228 to DCTN1-203.
- Functionally, K181E homozygous cells had reduced MAP2 staining and reduced neurite length, whereas K181E heterozygous cells showed increased MAP2 staining and longer neurites in the undifferentiated condition; K263E cells showed differentiation deficits after differentiation began.
Methods
- CRISPR/Cas9 nucleofection with gRNA and HDR ssODN was used to introduce K181E or K263E into TARDBP in SH-SY5Y cells; homozygous and heterozygous clones were validated by Sanger sequencing, TARDBP cDNA integrity, Poldip3 splicing, TDP-43 immunofluorescence and cleaved caspase-3 viability assays.
- Bulk RNA-seq was performed on three independent RNA extractions per CRISPR clone and wild-type SH-SY5Y cells; libraries were poly(A)-selected and sequenced on NovaSeq 6000 (2x150-bp reads, minimum 30 million read pairs per sample), with analysis by kallisto v0.48, tximport, sleuth, fgsea/MSigDB and IsoformSwitchAnalyzeR.
- SH-SY5Y differentiation used retinoic acid followed by BDNF; immunofluorescence for MAP2 and beta-III-tubulin, RT-PCR for MAP2 and selected genes, and neurite tracing with NeuronJ on MAP2-stained cells (minimum 30 cells across three repeats) were used for functional validation.
Limitations
- Stated: the extent of disruption correlating with ageing and subsequent challenges still needs further investigation; how neurodevelopmental and neurodegenerative links may develop is not understood; no overt nuclear aggregates were seen at endogenous expression, possibly due to lack of challenge or insufficient expression to drive aggregation.
- Evident: all experiments are in the SH-SY5Y neuroblastoma cell line in vitro, not patient tissue or in vivo models; K263E showed no significant DEGs in the undifferentiated state, so transcriptomic conclusions are largely driven by K181E; only two RNA-binding-deficient TDP-43 mutations were studied.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures















Verification
Claims the paper makes
0 Valid · 1 Not valid · 44 Not checked · 73 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using a significance cut-off of q<0.1, we found no significant differential expressed genes (DEGs) between the K263E-TDP-43 cells and control cells (Supplementary Figure 2).”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Differences in K181E-TDP-43 homozygous and heterozygous transcriptomic profiles in comparison to wild-type cells observed by RNA-seq analysis.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When comparing K181E-TDP-43 cells with control, 233 and 167 DEGs were identified in K181E-TDP-43 homozygous and heterozygous cells respectively (q<0.1; Figure 2A-B, Supplementary Data 1).”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Differences in K181E-TDP-43 homozygous and heterozygous transcriptomic profiles in comparison to wild-type cells observed by RNA-seq analysis.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Other significant pathways down-regulated in K181E-TDP-43 homozygous cells included those related to transport, secretion and general biogenesis and signalling (Figure 3C; Supplementary Data 1), again indicating a potential functional compromise in neurite establishment and neuronal communication.”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Neuronal and synaptic pathways are significantly down-regulated in K181E-TDP-43 homozygous cells.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The known TDP-43 targets implicated in ALS disease pathogenesis, STMN2, UNC13A and NPTX2 (13)(14)(15)(16)34), also show this similar opposing expression pattern, being down-regulated in K181E-TDP-43 homozygous cells but up-regulated in K181E-TDP-43 heterozygous cells (Figure 3D).”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Neuronal and synaptic pathways are significantly down-regulated in K181E-TDP-43 homozygous cells.
What the sources say
- Not matchedcites (13)(14)(15)(16)34)
This doesn’t read as a citation we can look up.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Not matched
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Transcriptomic comparison revealed significant gene expression differences in neuronal and synaptic genes between K181E-TDP-43 homozygous and heterozygous cells compared to wild-type control.”
- Also stated in: § Abstract · plain
“Significant changes were identified in the transcriptomic profiles of these cells, in particular, between K181E homozygous and heterozygous cells, with the most affected genes involved in neuronal differentiation and synaptic pathways.”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Introduction
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Abstract · plain
51 more claims
Create a free account to see all 118 claims and to verify the 66 references still open.
- It may state two separate claims as one. 53
- Probably not a substantial claim. 23
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > SH-SY5Y differentiation
“Medium was refreshed every 2 days and cells harvested or fixed after 4 days in BDNF for further analysis.”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Dosage-dependent opposing effect of K181E-TDP-43
“fully differentiated (5 days after BDNF treatment).”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Dosage-dependent opposing effect of K181E-TDP-43
“All DEGs identified in K181E-TDP-43 homozygous vs WT(B) and K181E-TDP-43 heterozygous vs WT (C) are plotted in the heatmap.”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Dosage-dependent opposing effect of K181E-TDP-43
“A-B.Volcano plots showing genes with significantly altered expression in K181E-TDP-43 homozygous cells (A) or heterozygous cells (B) relative to un-edited control SH-SY5Y cells.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Gene expression profiling
“Gene Set Enrichment Analysis (GSEA) was run using the R package fgsea (27) using the prerank setting based on πvalues (-log10(q-value) x log2(fold change)) (28).”
§ Familial ALS/FTD-associated RNA-Binding deficient TDP-43 mutants cause neuronal and synaptic dysregulation in vitro > Dosage-dependent opposing effect of K181E-TDP-43
“πvalues (-log10(p-value) x log2(fold change)) were used as the rank of significance.”
Citations
Cites
R: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Fiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
BLAST+: architecture and applications
Camacho, C., Coulouris, G., Avagyan, V., Ma, N., Papadopoulos, J., Bealer, K., & Madden, T. L. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-421 · Cited by 22,074
Near-optimal probabilistic RNA-seq quantification
Bray, N. L., Pimentel, H., Melsted, P., & Pachter, L. (2016) · Nature Biotechnology · doi:10.1038/nbt.3519 · Cited by 9,723
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences
Soneson, C., Love, M. I., & Robinson, M. D. (2015) · F1000Research · doi:10.12688/f1000research.7563.1 · Cited by 3,929
Fast gene set enrichment analysis
Korotkevich, G., Sukhov, V., Budin, N., Shpak, B., Artyomov, M. N., & Sergushichev, A. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/060012 · Cited by 3,454
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
SRplot: A free online platform for data visualization and graphing
Tang, D., Chen, M., Huang, X., Zhang, G., Zeng, L., Zhang, G., Wu, S., & Wang, Y. (2023) · PLOS ONE · doi:10.1371/journal.pone.0294236 · Cited by 2,536
A census of human RNA-binding proteins
Gerstberger, S., Hafner, M., & Tuschl, T. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3813 · Cited by 2,032
Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images
Meijering, E., Jacob, M., Sarria, J. ‐. F., Steiner, P., Hirling, H., & Unser, M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20022 · Cited by 1,608
Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex
McEwen, B. S., Nasca, C., & Gray, J. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.171 · Cited by 1,574
Differential analysis of RNA-seq incorporating quantification uncertainty
Pimentel, H., Bray, N. L., Puente, S., Melsted, P., & Pachter, L. (2017) · Nature Methods · doi:10.1038/nmeth.4324 · Cited by 1,534
Stress granules and processing bodies are dynamically linked sites of mRNP remodeling
Kedersha, N., Stoecklin, G., Ayodele, M., Yacono, P., Lykke-Andersen, J., Fritzler, M. J., Scheuner, D., Kaufman, R. J., Golan, D. E., & Anderson, P. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200502088 · Cited by 1,490
Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS
Kim, H. J., Kim, N. C., Wang, Y.-D., Scarborough, E. A., Moore, J., Diaz, Z., MacLea, K. S., Freibaum, B., Li, S., Molliex, A., et al. (2013) · Nature · doi:10.1038/nature11922 · Cited by 1,475
Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man
Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M. A., & Glass, J. D. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.10.004 · Cited by 1,357
RNA-binding proteins: modular design for efficient function
Lunde, B. M., Moore, C., & Varani, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2178 · Cited by 1,321
RNA-binding proteins in human genetic disease
Gebauer, F., Schwarzl, T., Valcárcel, J., & Hentze, M. W. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00302-y · Cited by 1,176
Characterizing the RNA targets and position-dependent splicing regulation by TDP-43
Tollervey, J. R., Curk, T., Rogelj, B., Briese, M., Cereda, M., Kayikci, M., König, J., Hortobágyi, T., Nishimura, A. L., Župunski, V., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2778 · Cited by 1,165
TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
Lagier-Tourenne, C., Polymenidou, M., & Cleveland, D. W. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq137 · Cited by 1,021
Stress granules as crucibles of ALS pathogenesis
Li, Y. R., King, O. D., Shorter, J., & Gitler, A. D. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201302044 · Cited by 922
TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease
Amador‐Ortiz, C., Lin, W., Ahmed, Z., Personett, D., Davies, P., Duara, R., Graff‐Radford, N. R., Hutton, M. L., & Dickson, D. W. (2007) · Annals of Neurology · doi:10.1002/ana.21154 · Cited by 916
Encinas, M., Iglesias, M., Liu, Y., Wang, H., Muhaisen, A., Ceña, V., Gallego, C., & Comella, J. X. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750991.x · Cited by 820
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00025 · Cited by 774
Buratti, E., & Baralle, F. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104236200 · Cited by 700
TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD
Ling, J. P., Pletnikova, O., Troncoso, J. C., & Wong, P. C. (2015) · Science · doi:10.1126/science.aab0983 · Cited by 688
Stress duration modulates the spatiotemporal patterns of spine formation in the basolateral amygdala
Mitra, R., Jadhav, S., McEwen, B. S., Vyas, A., & Chattarji, S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504011102 · Cited by 663
Winton, M. J., Igaz, L. M., Wong, M. M., Kwong, L. K., Trojanowski, J. Q., & Lee, V. M.-Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800342200 · Cited by 659
ALS-implicated protein TDP-43 sustains levels of STMN2, a mediator of motor neuron growth and repair
Klim, J. R., Williams, L. A., Limone, F., Guerra San Juan, I., Davis-Dusenbery, B. N., Mordes, D. A., Burberry, A., Steinbaugh, M. J., Gamage, K. K., Kirchner, R., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0300-4 · Cited by 653
The tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease
King, O. D., Gitler, A. D., & Shorter, J. (2012) · Brain Research · doi:10.1016/j.brainres.2012.01.016 · Cited by 644
Mackenzie, I. R., Nicholson, A. M., Sarkar, M., Messing, J., Purice, M. D., Pottier, C., Annu, K., Baker, M., Perkerson, R. B., Kurti, A., et al. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.025 · Cited by 640
Melamed, Z., López-Erauskin, J., Baughn, M. W., Zhang, O., Drenner, K., Sun, Y., Freyermuth, F., McMahon, M. A., Beccari, M. S., Artates, J. W., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-018-0293-z · Cited by 635
Structural determinants of the cellular localization and shuttling of TDP-43
Ayala, Y. M., Zago, P., D'Ambrogio, A., Xu, Y.-F., Petrucelli, L., Buratti, E., & Baralle, F. E. (2008) · Journal of Cell Science · doi:10.1242/jcs.038950 · Cited by 630
Aberrant methylation of t RNA s links cellular stress to neuro‐developmental disorders
Blanco, S., Dietmann, S., Flores, J. V., Hussain, S., Kutter, C., Humphreys, P., Lukk, M., Lombard, P., Treps, L., Popis, M., et al. (2014) · The EMBO Journal · doi:10.15252/embj.201489282 · Cited by 620
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Zhang, Y.-J., Xu, Y.-F., Cook, C., Gendron, T. F., Roettges, P., Link, C. D., Lin, W.-L., Tong, J., Castanedes-Casey, M., Ash, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900688106 · Cited by 604
Wils, H., Kleinberger, G., Janssens, J., Pereson, S., Joris, G., Cuijt, I., Smits, V., Ceuterick-de Groote, C., Van Broeckhoven, C., & Kumar-Singh, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912417107 · Cited by 587
TDP-43 represses cryptic exon inclusion in the FTD-ALS gene UNC13A
Ma, X. R., Prudencio, M., Koike, Y., Vatsavayai, S. C., Kim, G., Harbinski, F., Briner, A., Rodriguez, C. M., Guo, C., Akiyama, T., et al. (2022) · Nature · doi:10.1038/s41586-022-04424-7 · Cited by 574
Krichevsky, A. M., & Kosik, K. S. (2001) · Neuron · doi:10.1016/s0896-6273(01)00508-6 · Cited by 536
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A
Brown, A.-L., Wilkins, O. G., Keuss, M. J., Kargbo-Hill, S. E., Zanovello, M., Lee, W. C., Bampton, A., Lee, F. C. Y., Masino, L., Qi, Y. A., et al. (2022) · Nature · doi:10.1038/s41586-022-04436-3 · Cited by 529
Arnold, E. S., Ling, S.-C., Huelga, S. C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H. B., McAlonis-Downes, M., Platoshyn, O., Parone, P. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222809110 · Cited by 492
Identification of Neuronal RNA Targets of TDP-43-containing Ribonucleoprotein Complexes
Sephton, C. F., Cenik, C., Kucukural, A., Dammer, E. B., Cenik, B., Han, Y., Dewey, C. M., Roth, F. P., Herz, J., Peng, J., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190884 · Cited by 434
The Heat Shock Response: Systems Biology of Proteotoxic Stress in Aging and Disease
Morimoto, R. I. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2012.76.010637 · Cited by 407
Uryu, K., Nakashima-Yasuda, H., Forman, M. S., Kwong, L. K., Clark, C. M., Grossman, M., Miller, B. L., Kretzschmar, H. A., Lee, V. M.-Y., Trojanowski, J. Q., et al. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31817713b5 · Cited by 382
HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells
Yu, H., Lu, S., Gasior, K., Singh, D., Vazquez-Sanchez, S., Tapia, O., Toprani, D., Beccari, M. S., Yates, J. R., Da Cruz, S., et al. (2021) · Science · doi:10.1126/science.abb4309 · Cited by 353
Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis
Kraemer, B. C., Schuck, T., Wheeler, J. M., Robinson, L. C., Trojanowski, J. Q., Lee, V. M. Y., & Schellenberg, G. D. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0659-0 · Cited by 350
Vitting-Seerup, K., & Sandelin, A. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz247 · Cited by 338
A novel significance score for gene selection and ranking
Xiao, Y., Hsiao, T.-H., Suresh, U., Chen, H.-I. H., Wu, X., Wolf, S. E., & Chen, Y. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btr671 · Cited by 325
Self-citationMutations in TDP-43 link glycine-rich domain functions to amyotrophic lateral sclerosis
Pesiridis, G. S., Lee, V. M.-Y., & Trojanowski, J. Q. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp303 · Cited by 324
A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis
Schaefer, A. M., Sanes, J. R., & Lichtman, J. W. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20620 · Cited by 248
Neurotoxic effects of TDP-43 overexpression in C. elegans
Ash, P. E. A., Zhang, Y.-J., Roberts, C. M., Saldi, T., Hutter, H., Buratti, E., Petrucelli, L., & Link, C. D. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq230 · Cited by 248
Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies
Baughn, M. W., Melamed, Z., López-Erauskin, J., Beccari, M. S., Ling, K., Zuberi, A., Presa, M., Gonzalo-Gil, E., Maimon, R., Vazquez-Sanchez, S., et al. (2023) · Science · doi:10.1126/science.abq5622 · Cited by 239
Neuroinflammation and Oxidative Stress in the Pathogenesis of Autism Spectrum Disorder
Usui, N., Kobayashi, H., & Shimada, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065487 · Cited by 237
Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia
Prudencio, M., Humphrey, J., Pickles, S., Brown, A.-L., Hill, S. E., Kachergus, J. M., Shi, J., Heckman, M. G., Spiegel, M. R., Cook, C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci139741 · Cited by 231
TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea
Kovacs, G. G., Murrell, J. R., Horvath, S., Haraszti, L., Majtenyi, K., Molnar, M. J., Budka, H., Ghetti, B., & Spina, S. (2009) · Movement Disorders · doi:10.1002/mds.22697 · Cited by 198
Hsieh, Y.-C., Guo, C., Yalamanchili, H. K., Abreha, M., Al-Ouran, R., Li, Y., Dammer, E. B., Lah, J. J., Levey, A. I., Bennett, D. A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.104 · Cited by 196
Yang, C., Tan, W., Whittle, C., Qiu, L., Cao, L., Akbarian, S., & Xu, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015878 · Cited by 189
Chen, H.-J., Mitchell, J. C., Novoselov, S., Miller, J., Nishimura, A. L., Scotter, E. L., Vance, C. A., Cheetham, M. E., & Shaw, C. E. (2016) · Brain · doi:10.1093/brain/aww028 · Cited by 181
Self-citationFratta, P., Sivakumar, P., Humphrey, J., Lo, K., Ricketts, T., Oliveira, H., Brito‐Armas, J. M., Kalmar, B., Ule, A., Yu, Y., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201798684 · Cited by 170
Bloh, K., Kanchana, R., Bialk, P., Banas, K., Zhang, Z., Yoo, B.-C., & Kmiec, E. B. (2021) · The CRISPR Journal · doi:10.1089/crispr.2020.0022 · Cited by 165
Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort
Ticozzi, N., Silani, V., LeClerc, A. L., Keagle, P., Gellera, C., Ratti, A., Taroni, F., Kwiatkowski, T. J., McKenna-Yasek, D. M., Sapp, P. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bbff05 · Cited by 160
Zeitelhofer, M., Karra, D., Macchi, P., Tolino, M., Thomas, S., Schwarz, M., Kiebler, M., & Dahm, R. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0104-08.2008 · Cited by 137
RRM adjacent TARDBP mutations disrupt RNA binding and enhance TDP-43 proteinopathy
Chen, H.-J., Topp, S. D., Hui, H. S., Zacco, E., Katarya, M., McLoughlin, C., King, A., Smith, B. N., Troakes, C., Pastore, A., et al. (2019) · Brain · doi:10.1093/brain/awz313 · Cited by 132
Self-citationCellular stress and apoptosis contribute to the pathogenesis of autism spectrum disorder
Dong, D., Zielke, H. R., Yeh, D., & Yang, P. (2018) · Autism Research · doi:10.1002/aur.1966 · Cited by 124
Rbfox3-regulated alternative splicing of Numb promotes neuronal differentiation during development
Kim, K. K., Nam, J., Mukouyama, Y.-S., & Kawamoto, S. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201206146 · Cited by 120
Overproduction of Upper-Layer Neurons in the Neocortex Leads to Autism-like Features in Mice
Fang, W.-Q., Chen, W.-W., Jiang, L., Liu, K., Yung, W.-H., Fu, A. K. Y., & Ip, N. Y. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.003 · Cited by 114
Shiga, A., Ishihara, T., Miyashita, A., Kuwabara, M., Kato, T., Watanabe, N., Yamahira, A., Kondo, C., Yokoseki, A., Takahashi, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043120 · Cited by 102
Sun, M., Bell, W., LaClair, K. D., Ling, J. P., Han, H., Kageyama, Y., Pletnikova, O., Troncoso, J. C., Wong, P. C., & Chen, L. L. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1701-2 · Cited by 101
The Role of PTEN in Neurodevelopment
Skelton, P. D., Stan, R. V., & Luikart, B. W. (2019) · Complex Psychiatry · doi:10.1159/000504782 · Cited by 98
Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members
Devenney, E. M., Ahmed, R. M., Halliday, G., Piguet, O., Kiernan, M. C., & Hodges, J. R. (2018) · Neurology · doi:10.1212/wnl.0000000000006344 · Cited by 97
Lin, Y.-S., Wang, H., Huang, D.-F., Hsieh, P.-F., Lin, M.-Y., Chou, C., Wu, I.-J., Huang, G., Gau, S. S., & Huang, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164164 · Cited by 92
RNA as a key factor in driving or preventing self-assembly of the TAR DNA-binding protein 43
Zacco, E., Graña-Montes, R., Martin, S. R., de Groot, N. S., Alfano, C., Tartaglia, G. G., & Pastore, A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.01.028 · Cited by 89
Quadros, A. R. A. D. A., Li, Z., Wang, X., Ndayambaje, I. S., Aryal, S., Ramesh, N., Nolan, M., Jayakumar, R., Han, Y., Stillman, H., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-023-02655-0 · Cited by 82
Capizzi, M., Carpentier, R., Denarier, E., Adrait, A., Kassem, R., Mapelli, M., Couté, Y., & Humbert, S. (2022) · Neuron · doi:10.1016/j.neuron.2021.10.033 · Cited by 82
RBFOX3/NeuN is Required for Hippocampal Circuit Balance and Function
Wang, H.-Y., Hsieh, P.-F., Huang, D.-F., Chin, P.-S., Chou, C.-H., Tung, C.-C., Chen, S.-Y., Lee, L.-J., Gau, S. S.-F., & Huang, H.-S. (2015) · Scientific Reports · doi:10.1038/srep17383 · Cited by 80
De Conti, L., Akinyi, M. V., Mendoza-Maldonado, R., Romano, M., Baralle, M., & Buratti, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv814 · Cited by 80
Inhibition of TDP-43 Aggregation by Nucleic Acid Binding
Huang, Y.-C., Lin, K.-F., He, R.-Y., Tu, P.-H., Koubek, J., Hsu, Y.-C., & Huang, J. J.-T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064002 · Cited by 79
RNA-binding proteins in neurological diseases
Zhou, H., Mangelsdorf, M., Liu, J., Zhu, L., & Wu, J. Y. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4647-9 · Cited by 79
Oxidative stress induces overgrowth of the Drosophila neuromuscular junction
Milton, V. J., Jarrett, H. E., Gowers, K. H. C., Chalak, S., Briggs, L., Robinson, I. M., & Sweeney, S. T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014511108 · Cited by 74
Zacco, E., Martin, S. R., Thorogate, R., & Pastore, A. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00372 · Cited by 73
A model of human neural networks reveals NPTX2 pathology in ALS and FTLD
Hruska-Plochan, M., Wiersma, V. I., Betz, K. M., Mallona, I., Ronchi, S., Maniecka, Z., Hock, E.-M., Tantardini, E., Laferriere, F., Sahadevan, S., et al. (2024) · Nature · doi:10.1038/s41586-024-07042-7 · Cited by 69
ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration
Watanabe, S., Oiwa, K., Murata, Y., Komine, O., Sobue, A., Endo, F., Takahashi, E., & Yamanaka, K. (2020) · Molecular Brain · doi:10.1186/s13041-020-0550-4 · Cited by 66
LRRK2 and GBA Variants Exert Distinct Influences on Parkinson’s Disease-Specific Metabolic Networks
Schindlbeck, K. A., Vo, A., Nguyen, N., Tang, C. C., Niethammer, M., DHAWAN, V. M., Brandt, V. L., Saunders-Pullman, R. J., Bressman, S., & Eidelberg, D. (2019) · Cerebral Cortex · doi:10.1093/cercor/bhz280 · Cited by 61
Fernandez, F. R., Via, G., Canavier, C. C., & White, J. A. (2022) · eNeuro · doi:10.1523/eneuro.0441-21.2022 · Cited by 59
Buratti, E., & Baralle, F. E. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08257.x · Cited by 59
Clinical and neuropathological features of ALS/FTD with TIA1 mutations
Hirsch-Reinshagen, V., Pottier, C., Nicholson, A. M., Baker, M., Hsiung, G.-Y. R., Krieger, C., Sengdy, P., Boylan, K. B., Dickson, D. W., Mesulam, M., et al. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0493-x · Cited by 56
Loss of TDP-43 induces synaptic dysfunction that is rescued by UNC13A splice-switching ASOsPreprint
Keuss, M. J., Harley, P., Ryadnov, E. M., Jackson, R. E., Zanovello, M., Wilkins, O. G., Barattucci, S., Mehta, P. R., Oliveira, M. G., Parkes, J. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.20.599684 · Cited by 50
Neurodegeneration and RNA‐binding proteins
De Conti, L., Baralle, M., & Buratti, E. (2017) · WIREs RNA · doi:10.1002/wrna.1394 · Cited by 48
Cheng, N., Alshammari, F., Hughes, E., Khanbabaei, M., & Rho, J. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179409 · Cited by 46
JNK Signalling Mediates Context-Dependent Responses to Reactive Oxygen Species in Neurons
Ugbode, C., Garnham, N., Fort‐Aznar, L., Evans, G. J. O., Chawla, S., & Sweeney, S. T. (2019) · Redox Biology · doi:10.1016/j.redox.2020.101712 · Cited by 36
Imaizumi, K., Ideno, H., Sato, T., Morimoto, S., & Okano, H. (2022) · eneuro · doi:10.1523/eneuro.0061-22.2022 · Cited by 33
Watson, A. M. M., Pribadi, M., Chowdari, K. V., Clifton, S., Wood, J. A., Miller, B. L., Coppola, G., & Nimgaonkar, V. L. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.12.007 · Cited by 29
Lulé, D. E., Ludolph, A. C., & Ludolph, A. G. (2008) · Medical Hypotheses · doi:10.1016/j.mehy.2007.11.002 · Cited by 24
Tau, RNA, and RNA-Binding Proteins: Complex Interactions in Health and Neurodegenerative Diseases
Lester, E., & Parker, R. (2023) · The Neuroscientist · doi:10.1177/10738584231154551 · Cited by 19
RNA-binding proteins and neural development: a matter of targets and complexes
Agnès, F., & Perron, M. (2004) · NeuroReport · doi:10.1097/00001756-200412030-00001 · Cited by 17
Hart, M. P. (2019) · Genetics · doi:10.1534/genetics.119.302415 · Cited by 17
Reduced levels of ALS gene DCTN1 induce motor defects in Drosophila
Borg, R. M., Herrera, P., Purkiss, A., Cacciottolo, R., & Cauchi, R. J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1164251 · Cited by 14
Stathmin 2 is a potential treatment target for TDP-43 proteinopathy in amyotrophic lateral sclerosis
Liu, Y., Yan, D., Yang, L., Chen, X., Hu, C., & Chen, M. (2024) · Translational Neurodegeneration · doi:10.1186/s40035-024-00413-0 · Cited by 9
Psychiatric disorders in C9orf72 kindreds: Study of 1,414 family members
(2019) · Neurology · doi:10.1212/wnl.0000000000007383 · Cited by 4
Research works printed but not linked: 4
- Mulligan, M.R. and Bicknell, L.S. (2023) The molecular genetics of nELAVL in brain development and disease. European Journal of Human Genetics, 31, 1209-1217.
- Basha, M.R., Wei, W., Bakheet, S.A., Benitez, N., Siddiqi, H.K., Ge, Y.W., Lahiri, D.K. and Zawia, N.H. (2005) The fetal basis of amyloidogenesis: Exposure to lead and latent overexpression of amyloid precursor protein and β-amyloid in the aging brain. Journal of Neuroscience, 25, 823-829.
- Stillman, B. and Stewart, D. (2007) Regulatory RNAs. Cold Spring Harbor Laboratory Press, 978, 313-320.
- Andrews, S. (2019) FastQC: A quality control tool for high throughput sequence data. FastQC: A quality control tool for high throughput sequence data.
Cited by
RNA Degradation in Pluripotent Stem Cells: Mechanisms, Crosstalk, and Fate Regulation
Jeong, S., Oh, M., Han, J., & Kim, S.-K. (2025) · Cells · doi:10.3390/cells14201634 · Cited by 5
Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS
López‐Blanch, R., Oriol‐Caballo, M., Estrela, J. M., & Obrador, E. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106727 · Cited by 3
TDP-43: [GU]-ardian of the transcriptome
Sinha, I. R., Atkinson, A. L., Irwin, K. E., Ling, J. P., & Wong, P. C. (2026) · Molecular Neurodegeneration · doi:10.1186/s13024-026-00944-2 · Cited by 2
McLellan, C., Campos‐Melo, D., Hammond, R. R., & Strong, M. J. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03005-6
Crossroad of motor neuron disease and dementia: Insights from TDP-43 RNA-binding deficiency
Magarotto, M., & Chen, H.-J. (2026) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-01285
Self-citation
Metadata
- Authors
- Magarotto, M., Gawne, R. T., Vilkaite, G., Beltrami, M., Mason, A. S., & Chen, H.-J.
- Affiliations
- University of York (GB)
- Corresponding author
- Chen, Han-Jou
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2025-06-30
- Volume
- 34
- Issue
- 17
- Pages
- 1480-1494
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W4411927652
- Cited by
- 5
- References
- 100
- Citations by year
- 2026: 4 · 2025: 1
- FWCI
- 2.20
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Human Molecular Genetics (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (submittedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- British Heart Foundation and Diabetes UK (SBF006\1088)
- ASM’s York Against Cancer
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Keywords
- TDP-43, amyotrophic lateral sclerosis, frontotemporal dementia, familial mutation, transcriptome dysregulation, neuronal differentiation, synaptic dysfunction, neurite morphology, neurodegeneration, SH-SY5Y cells, CRISPR/Cas9 knock-in
- MeSH terms
- Amyotrophic Lateral Sclerosis, Cell Differentiation, DNA-Binding Proteins, Humans, Mutation, Neurons, Synapses, RNA-Binding Proteins, Cell Line, Tumor, Frontotemporal Dementia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.